Anne-Marie Birkill's path to venture capital is unusual: she spent about 15 years in agri-business developing and commercializing new plant varieties before co-founding OneVentures in 2010 with a team that came from science and medicine rather than finance or law, and she personally sourced OneVentures' investment in UQ spinout Vaxxas, staying involved as a main investor for well over a decade. She's also known for telling founders plainly that venture capital only suits a small share of businesses, often pointing them toward grants or other funding instead, and she co-founded Women in Biotechnology to support women entering the field.